Skip to main content
Erschienen in: Malaria Journal 1/2018

Open Access 01.12.2018 | Research

Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia

verfasst von: Patrick McCreesh, Davis Mumbengegwi, Kathryn Roberts, Munyaradzi Tambo, Jennifer Smith, Brooke Whittemore, Gerard Kelly, Caitlin Moe, Max Murphy, Mukosha Chisenga, Bryan Greenhouse, Henry Ntuku, Immo Kleinschmidt, Hugh Sturrock, Petrina Uusiku, Roland Gosling, Adam Bennett, Michelle S. Hsiang

Erschienen in: Malaria Journal | Ausgabe 1/2018

Abstract

Background

Subpatent malaria infections, or low-density infections below the detection threshold of microscopy or standard rapid diagnostic testing (RDT), can perpetuate persistent transmission and, therefore, may be a barrier for countries like Namibia that are pursuing malaria elimination. This potential burden in Namibia has not been well characterized.

Methods

Using a two-stage cluster sampling, cross-sectional design, subjects of all age were enrolled during the end of the 2015 malaria transmission season in Zambezi region, located in northeast Namibia. Malaria RDTs were performed with subsequent gold standard testing by loop-mediated isothermal amplification (LAMP) using dried blood spots. Infection prevalence was measured and the diagnostic accuracy of RDT calculated. Relationships between recent fever, demographics, epidemiological factors, and infection were assessed.

Results

Prevalence of Plasmodium falciparum malaria infection was low: 0.8% (16/1919) by RDT and 2.2% (43/1919) by LAMP. All but one LAMP-positive infection was RDT-negative. Using LAMP as gold standard, the sensitivity and specificity of RDT were 2.3% and 99.2%, respectively. Compared to LAMP-negative infections, a higher portion LAMP-positive infections were associated with fever (45.2% vs. 30.4%, p = 0.04), though 55% of infections were not associated with fever. Agricultural occupations and cattle herding were significantly associated with LAMP-detectable infection (Adjusted ORs 5.02, 95% CI 1.77–14.23, and 11.82, 95% CI 1.06–131.81, respectively), while gender, travel, bed net use, and indoor residual spray coverage were not.

Conclusions

This study presents results from the first large-scale malaria cross-sectional survey from Namibia using molecular testing to characterize subpatent infections. Findings suggest that fever history and standard RDTs are not useful to address this burden. Achievement of malaria elimination may require active case detection using more sensitive point-of-care diagnostics or presumptive treatment and targeted to high-risk groups.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12936-018-2626-5) contains supplementary material, which is available to authorized users.
Abkürzungen
RDT
rapid diagnostic tests
LAMP
loop mediated isothermal amplification
HRP2
histidine-rich protein 2
ITN
insecticide-treated bed net
IRS
indoor-residual spraying
nPCR
nested PCR
ODK
Open Data Kit
DBS
dried blood spot

Background

Subpatent malaria infections, or low-density malaria infections below the detection threshold of standard rapid diagnostic tests (RDT) or microscopy, may be responsible for at least 20–50% of malaria transmission in pre-elimination and elimination settings [14]. As such, they are a key target for countries aiming to reduce or interrupt transmission [5]. These infections have generally been considered asymptomatic or minimally symptomatic, but there is also increasing data to suggest they are associated with adverse health effects including recurrent episodes of symptomatic parasitaemia, chronic anaemia, maternal and neonatal mortality, co-infection with invasive bacterial disease, and cognitive impairment [6].
A better understanding of the prevalence and characteristics of subpatent infections can inform the design of targeted strategies for malaria elimination [79]. Namibia is a low transmission country in southern Africa that has experienced a tremendous decline in reported malaria cases over the past decade due to the successful implementation of malaria control interventions. The country is now aiming to eliminate malaria [10], but the burden of subpatent infections has not been well-characterized [11, 12]. To address this gap, a large household-based cross-sectional survey was conducted in Zambezi region, Namibia. The study aimed to: (1) measure the prevalence of subpatent infection using loop-mediated isothermal amplification (LAMP), a molecular detection method, (2) measure the diagnostic accuracy of standard RDT using LAMP as gold standard, and (3) identify potential risk factors for subpatent malaria infection.

Methods

Study setting

Zambezi region is located in the northern malarious area of Namibia, and shares borders with the higher malaria endemic countries of Angola and Zambia (Fig. 1a). It is a primarily rural setting with most of the population engaged in subsistence farming. From 2004 to 2015, the annual parasite incidence in Zambezi fell from over 600 to 17.1 cases per 1000 in 2014 [12, 13]. This decline in incidence occurred in the setting of improved implementation of indoor residual spraying (IRS), distribution and use of long-lasting insecticide-treated bed nets (ITNs), increased RDT use, and treatment of confirmed cases with artemisinin-based combination therapy. With high temperatures and significant seasonal rainfall, Zambezi region is the wettest region in Namibia. Following the wet season of October to May, the high transmission season typically begins in November, peaks between January and April, and then trails off in May. Reported malaria cases are almost all due to Plasmodium falciparum and the most common malaria vector species is Anopheles arabiensis [14].

Study design and sample size

This cross-sectional survey was carried out at the end of the transmission season from April to June 2015 in the historically higher burden western part of Zambezi region (Fig. 1a), where based on the 2011 census data and projected growth rate, the estimated population size of the study area in 2015 was 35,381 [15]. In early 2015, the households in the study area were mapped and health facility catchment areas were defined, providing a household sampling frame for this survey. A two-stage, cluster sampling design was employed, where six of the eleven health facilities within the study area were randomly selected. Households from the selected health facility catchment areas were then randomly selected for inclusion in the survey.
The total target sample size was 2000 participants to detect a 5% prevalence based on LAMP with 80% study power and 5% significance level. These calculations assumed a 10% refusal rate, design effect of two (to account for correlations between clusters at the health facility level), annual parasite incidence (API) of at least 15/1000, 40% probability of clinical symptoms, 51% probability of seeing care at a health facility if febrile, 85% RDT diagnostic sensitivity for symptomatic infections, and 50% prevalence of annual incidence infections during the survey [16, 17]. Assuming an average of six individuals per household and that 10% of households would not be enrolled, 540 households was determined to be sufficient to reach the target sample size. However, 23% of households could not be enrolled due to absence or having moved away. Toward the end of the survey, an additional 144 households were randomly selected for recruitment.

Participants

All individuals in selected households were eligible for inclusion in the survey if they were usual residents of the household or had slept in the household the night before. A complete line listing of all eligible individuals was generated at the first visit and subjects were excluded if they refused to participate, were too ill to participate, or were not present at any of three visits to each household.

Data collection

Selected households were approached for written informed consent, which was conducted at the individual level and from a parent or guardian for minors less than 18 years of age. Additionally, minor assent was obtained for children > 12 years of age. Blood was collected by finger prick from all consenting participants for malaria testing by Carestart Malaria HRP2/pLDH (Pf/PAN) RDT (AccessBio, Somerset, NJ) and to generate a dried blood spot (DBS) using Whatmann 3 MM filter paper (GE Healthcare, Chicago, IL). Presence of clinical symptoms was assessed by self-report of fever in the prior 2 weeks. Infections associated with lack of self-reported fever were considered subclinical. Participants were interviewed in the local language SiLozi using a standardized tablet-based household questionnaire (administered to the household head or other adult representative) and individual questionnaire via Open Data Kit (ODK) software.
Household level data included the household location, socioeconomic status, household population, ITN ownership, as well as IRS coverage in the past 12 months. Questions assessing socioeconomic status included assessment of water source and household assets including electricity, radios, televisions, mobile phones, and refrigerators. The individual questionnaire assessed demographics, travel history, vector control coverage and use, history of malaria, and care-seeking behaviour associated with fever the past 2 weeks. All RDT positive individuals were considered to have uncomplicated malaria and received treatment in the field with artemether-lumefantrine according to national guidelines [18]. Subjects with severe malaria or illness not attributable to malaria were referred to the nearest health facility after assessment by study nurses. Up to two return visits were made to each household to maximize enrollment, with the goal to enroll at least 80% of residents within each household.

Laboratory methods

DBS cards were transported to the University of Namibia Multi-Disciplinary Research Center laboratory in Windhoek. DNA was extracted using the Saponin/Chelex method previously described [19]. Using 15 µL of DNA extraction product, Plasmodium-specific testing was conducted using a commercial loop-mediated isothermal amplification kit (PAN-LAMP Loopamp detection kit, Eiken Chemical, Japan) in accordance with manufacturer’s instructions [20]. For quality assurance, all samples that were positive by RDT and/or PAN-LAMP and a random sampling of 10% of samples that were negative by RDT and LAMP underwent further testing by nested PCR (nPCR) targeting the cytochrome b gene, followed by species identification via AluI digest for nPCR positives [21]. Five microliter of DNA extraction product was used for nPCR. For any LAMP/nPCR discordant results, nPCR was repeated two additional times; nPCR was considered positive if at least one of the three results was positive. For LAMP and nPCR positive controls with parasite densities of at least 1 to 5 parasites/µL and 0.1 to 1 parasites/µL, respectively, were used.

Data management and statistical analysis

Survey data were uploaded from tablet devices to a secure cloud-based sever at least weekly. Data were analysed using STATA (version 14.0; STATA Corp., College Station, TX, USA). Locations of cases were mapped using QGIS (version 2.16.2). Prevalence of malaria infection by RDT and LAMP were estimated and compared. Diagnostic accuracy of RDT was calculated using LAMP as gold standard. Based on the nPCR results of 10% of negative cases and all discordant LAMP and RDT samples, quality assurance of LAMP was assessed by calculating sensitivity and specificity of LAMP using nPCR as a gold standard. Demographic and epidemiological characteristics of participants were described. A housing quality variable was constructed by a principal component analysis based on type of wall, roof, window, and eaves. A socioeconomic status index was generated by principal component analysis based on six household assets ownership variables, wall type, roof type, and household water source.
Associations between covariates and LAMP-detectable malaria infection were explored using Chi squared and Fisher’s exact tests (Table 2). Epidemiological covariates with a p value of less than 0.10 in this bivariate analysis were included in multivariate logistic regression models, with gender, age, and socioeconomic status included a priori. Comparisons accounted for clustering at the highest level [22, 23] (by health facility catchment area) using robust standard errors. Reported fever in the prior 2 weeks was not included in the multivariate analysis due to it not being an epidemiological risk factor and its association with the outcome of infection. However, fever history was used for a stratified analysis of the diagnostic accuracy of RDT using LAMP as gold standard. Among the subset of individuals with fever history, the association between care-seeking behaviour and LAMP detectable malaria infection was also assessed separately. To investigate the distribution of malaria infection within the study area, spatial clusters of high malaria prevalence were identified using Kulldorff’s spatial scan statistic SaTScan™ v9.4 (SaTScan Boston, MA). Clustering was assessed using a spatial Bernoulli model (no other environmental covariates were included) with a maximum radius of 5 km and statistical significance tested by likelihood ratio, based on 999 Monte Carlo repetitions [24].

Results

Enrollment

Of the 684 households sampled from the six catchment areas, 529 (77.3%) were enrolled (Fig. 2). Among 2290 eligible individuals in enrolled households, 1919 (83.8%) were tested by RDT and LAMP. The most common reason for lack of enrollment was that no household head was present after three visits by study teams. The most common reasons blood testing was not performed were absence (7.2%) and DBS not available (not collected, lost or insufficient blood) (6.5%).

Study population characteristics

Study population characteristics are shown in Table 1. A slightly higher proportion of enrollees were female (55.0%) than male and the largest age group enrolled was children 15 years old or younger (47.0%). The most common occupation was agriculture representing 12.6% (241/1919) of all subjects, and 23.7% (241/1016) of the population over 15 years of age. Almost a quarter (23.1%) of the total adult population was unemployed. Fifteen percent of participants reported travel in the previous 1 to 8 weeks, with most travel being domestic (94.1%) rather than international (5.9%). Fever in the last 2 weeks was reported by 30.8% of participants. Overall, 33.1% of participants reported using an ITN the previous night and 59.6% of individuals lived in a household that received IRS in the past 12 months.
Table 1
Characteristics of study population, and association between clinical, demographic, and epidemiological factors and malaria infection
 
Total (%)
n = 1919
LAMP negative (%)
n = 1876
LAMP positive (%)
n = 42
p-value
Clinical
 Fever in the past 2 weeks
  No
1292 (69.2)
1269 (98.2)
23 (1.8)
0.04
  Yes
574 (30.8)
555 (96.7
19 (3.3)
Demographics
 Gender
  Female
1056 (55.0)
1033 (97.8)
23 (2.2)
0.84
  Male
863 (45.0)
843 (97.7)
20 (2.3)
 Age (years)
  < 15
902 (47.0)
889 (98.6)
13 (1.4)
0.07
  15–40
629 (32.8)
609 (96.8)
20 (3.2)
  > 40
387 (20.2)
378 (97.4)
10 (2.6)
 Occupationa
  Agricultural
241 (12.6)
229 (95.0)
12 (4.9)
0.001
  Fishing
25 (1.3)
24 (96.0)
1 (4.0)
  Cattle herder
27 (1.4)
24 (88.9)
3 (11.1)
  Other manual labour
51 (2.7)
49 (96.1)
2 (3.9)
  Police officer/guard
16 (0.8)
16 (100)
0 (0)
  Office/commercial/professional
28 (1.5)
27 (96.4)
1 (3.6)
  Small market sales
27 (1.4)
27 (100)
0 (0)
  Unemployed/homemaker/retiree
443 (23.1)
438 (98.9)
5 (1.1)
  Student
146 (7.6)
142 (97.3)
4 (2.7)
  Otherb
13 (0.7)
11 (84.6)
2 (15.4)
  ≤ 15 years old
902 (47.0)
889 (98.6)
13 (1.4)
 Socio-economic status
  Lowest
368 (19.7)
360 (97.8)
8 (2.2)
0.99
  Lower-middle
353 (18.9)
345 (97.7)
8 (2.3)
  Middle
380 (20.3)
372 (97.9)
8 (2.1)
  Upper-middle
384 (20.6)
376 (97.9)
8 (2.1)
  Highest
384 (20.6)
374 (97.4)
10 (2.6)
Residence
 Health facility catchment area
  Chinchimane
179 (9.3)
174 (97.2)
5 (2.8)
0.83
  Choi
308 (16.1)
300 (97.4)
8 (2.6)
  Kanono
226 (11.9)
221 (97.8)
5 (2.2)
  Kasheshe
340 (17.7)
331 (97.4)
9 (2.6)
  Sesheke
462 (24.1)
455 (98.5)
7 (1.5)
  Sibbinda
403 (21.0)
394 (97.8)
9 (2.2)
Travel
 Travel in past 8 weeks
  No
1597 (85.5)
1560 (97.7)
37 (2.2)
0.17
  Yes
270 (14.5)
263 (97.4)
7 (2.4)
 Travel categories
    
  No travel
1597 (85.5)
1562 (97.8)
35 (2.2)
0.76
  Domestic travel
256 (13.7)
249 (97.3)
7 (2.1)
  International travel
16 (0.9)
16 (100)
0 (0)
Housing
 Tertile of housing qualityc
  Lowest
866 (46.4)
849 (98.0)
17 (2.0)
0.74
  Middle
405 (21.7)
395 (97.5)
10 (2.5)
  Highest
594 (31.9)
579 (97.5)
15 (2.5)
 Individuals per household
  < 5
194 (10.6)
192 (99.0)
2 (1.0)
0.50
  ≥ 5 and < 10
1011 (55.1)
988 (97.7)
23 (2.3)
  ≥ 10
629 (34.3)
613 (97.5)
16 (2.5)
Vector control
 ITN ownership
  None
854 (45.6)
834 (97.7)
20 (2.3)
0.88
  < 1 ITN per 2 people
647 (34.6)
634 (98.0)
13 (2.0)
  ≥ 1 ITN per 2 people
371 (19.8)
362 (97.6)
9 (2.4)
 ITN use
  No
1250 (66.9)
1226 (98.1)
24 (1.9)
0.18
  Yes
619 (33.1)
601 (97.1)
18 (2.9)
 Sprayed in past year
  No
723 (40.4)
710 (98.2)
13 (1.8)
0.36
  Yes
1065 (59.6)
1039 (97.6)
26 (2.4)
LAMP loop-mediated isothermal amplification, RDT rapid diagnostic test, ITN insecticide treated bed net, IRS indoor residual spraying
aOccupation was only assessed for participants over 15 years of age
bHerbalist, healer, bartender, land surveyor, soldier, headman
cHousing quality tertiles based on principle component analysis of wall type, roof type, eaves, and windows

Prevalence of malaria infection

The overall prevalence of Plasmodium infection detected by RDT was 0.8%, 95% CI 0.4% to 1.2% (16/1919). By LAMP, prevalence was 2.2%, 95% CI 1.6% to 2.9% (43/1919) and in subsequent nPCR testing, all LAMP-positive infections were identified as P. falciparum mono-infection. Malaria prevalence by health facility catchment area ranged from 0 and 1.7% by RDT and 1.5 to 2.8% by LAMP. There were no statistically significant differences in malaria prevalence by health facility catchment area (χ2 = 1.80, p = 0.88).
Figure 1b shows the spatial distribution of study participants and RDT and LAMP detected infections, which reflects the population distribution along major roads. In the SatScan analysis, no statistically significant clusters of malaria infection were observed over the entire study area or within health facility catchment areas.

Diagnostic accuracy

Compared to 2.2% infection prevalence by LAMP, prevalence of infection by RDT was only 0.8%. There was little concordance between RDT and LAMP positivity, with only one participant positive by both detection methods. Of seven symptomatic individuals who were RDT positive and LAMP negative, 2 (28%) reported treatment with artemether–lumefantrine within the past 2 weeks. Using LAMP as gold standard, the diagnostic accuracy of RDT was assessed in the total study population and in those with and without fever in the previous 2 weeks (Table 2). The sensitivities and positive predictive values were extremely low in all groups and specificities and negative predictive values high in all groups.
Table 2
Diagnostic accuracy of RDT in total study population and those with and without fever in the past 2 weeks, using LAMP as gold standard (n = 1919)
 
Total (%, 95% CI)
Fever in past 2 weeks (%, 95% CI)
No fever in past 2 weeks (%, 95% CI)
Sensitivity
2.3 (0.06–13.8)
0 (0.0–20.9)
4.2 (0.2–23.1)
Specificity
99.2 (98.7–99.5)
98.7 (97.3–99.4)
99.4 (98.7–99.7)
Positive predictive value
6.3 (0.33–32.3)
0 (0–43.9)
11.1 (0.6–49.3)
Negative predictive value
97.8 (97.0–98.4)
96.6 (94.7–97.9)
98.3 (97.4–98.9)
Overall, the sensitivity and specificity of LAMP in the total study population using nPCR as the gold standard was 75.0% (95% CI 57.8–87.9) and specificity was 99.2% (95% CI 98.6–99.5), respectively. Among the samples that had repeat nPCR results, there were no discordant nPCR results. There was only one LAMP negative sample that was PCR positive. That all but one of the 15 RDT-positive LAMP-negative samples were confirmed negative by nPCR suggests that these samples were false RDT-positives (Additional file 1).

Risk factor assessment

The associations between different malaria risk factors and LAMP detectable malaria infection are shown in Table 1. There was no evidence of association between LAMP detectable malaria infection and gender. In both the unadjusted and adjusted analysis (Table 3), occupational status was strongly associated with LAMP detectable infection. Compared to unemployed participants, and adjusting for gender, age, socioeconomic status, and clustering at the health facility level, cattle herders (AOR 11.82, 95% CI 1.06–131.81) and agricultural occupations (AOR 5.02, 95% CI 1.77–14.23) were significantly more likely to have a LAMP detectable malaria infection. There was no evidence of an association between age group or household socioeconomic status, and malaria infection.
Table 3
Logistic regression analysis for potential risk factors associated with LAMP detectable malaria infection (n = 1869)
Potential risk factor for malaria infection
OR (95% CI)
AOR* (95% CI)
Gender
 Female
Ref
 
 Male
1.07 (0.58–1.95)
0.99 (0.42–2.30)
Age (years)
 < 15
Ref
 
 15–40
2.25 (1.11–4.55)
1.35 (0.50–3.65)
 > 40
1.81 (0.79–4.16)
0.79 (0.26–2.36)
Occupation
 Unemployed
Ref
 
 Student
2.47 (0.65–9.31)
2.12 (0.25–17.94)
 Office/clerical/commercial/professional
3.24 (0.37–28.76)
3.44 (0.21–57.40)
 Other manual labor
3.58 (0.68–18.92)
3.41 (0.11–107.45)
 Fishing
3.65 (0.41–32.48)
3.51 (0.65–19.01)
 Agricultural
4.55 (1.58–13.07)
5.02 (1.77–14.23)a
 Cattle herder
14.21 (2.97–68.12)
11.82 (1.06–131.81)b
 Otherc
15.93 (2.78–91.25)
11.26 (1.02–124.69)
Socioeconomic status quintile
 Lowest
Ref
 
 Lower-middle
1.04 (0.39–2.81)
0.85 (0.39–1.89)
 Middle
0.97 (0.36–2.61)
0.70 (0.22–2.21)
 Upper-middle
0.96 (0.36–2.58)
0.71 (0.17–2.99)
 Highest
1.20 (0.47–3.08)
0.85 (0.26–2.75)
OR odds ratio, AOR adjusted odds ratio
* Adjusted for gender, age, socioeconomic status, and clustering at the health facility level
ap-value = 0.01
bp-value = 0.04
cHerbalist, healer, bartender, land surveyor, soldier, headman

Care-seeking behaviour

Of participants who reported fever in the previous 2 weeks (n = 571), only 51.8% (95% CI 48.4% to 55.3%) reported seeking care (Table 4). Compared to LAMP-negative subjects, LAMP-positive subjects were less likely to seek care (31.6% versus 52.5%), though the association did not reach statistical significance (p = 0.07). Among all individuals with recent fever and who sought care, almost all (91.9%) did so at a public health facility. The most common reason for seeking care was household proximity to a health facility (86.9%). The most common reasons for not seeking care for fever were lack of money for care or transportation (59.7%), and illness was not considered serious enough (15.2%).
Table 4
Characteristics of subjects with fever in prior 2 weeks and association between care-seeking behaviour and infection
Sought care
Total (%)
LAMP negative (%)
LAMP positive (%)
p-value
n = 571
n = 552
n = 19
  No
275 (48.2)
262 (47.5)
13 (68.4)
0.07
  Yes
296 (51.8)
290 (52.5)
6 (31.6)
Care-seeking behaviour among subjects that sought care
Total (%)
LAMP negative (%)
LAMP positive (%)
p-value
n = 296
n = 290
n = 6
 Treatment source
  Public
272 (91.9)
266 (91.7)
6 (100)
0.99
  Other
24 (8.1)
24 (8.3)
0 (0)
 Days to seek treatment
  ≤ 1 day
138 (46.6)
135 (46.6)
3 (50.0)
0.83
  > 1 day and ≤ 1 week
141 (47.6)
138 (47.6)
3 (50.0)
  > 1 week
17 (5.7)
17 (5.9)
0 (0)
 Reasons for seeking treatment
  Close to home
246 (83.1)
240 (82.8)
6 (100)
1.00
  Other
50 (16.9)
50 (17.2)
0 (0)
Reasons for not seeking treatment among subjects that did not seek care
Total (%)
LAMP negative (%)
LAMP positive (%)
p-value
n = 275
n = 262
n = 13
  Lacked money for care or transportation
157 (57.1)
152 (58.0)
5 (38.5)
0.18
  Drugs not available
1 (0.4)
1 (0.4)
0 (0)
  Self-medication
13 (4.7)
11 (4.2)
2 (15.4)
  Long wait times at facility
3 (1.1)
3 (1.1)
0 (0)
  Distance/other transportation issue
17 (6.2)
17 (6.5)
0 (0)
  Illness not serious enough
40 (14.5)
36 (13.7)
4 (30.8)
  Other
44 (16.0)
42 (16.0)
2 (15.4)
Care-seeking only assessed for those who reported fever in the past 2 weeks. Treatment source, days to seek treatment and reasons for seeking care only assessed for those who sought treatment. Reason for not seeking care only assessed for those who did not seek treatment

Discussion

As a reservoir for persistent malaria transmission, subpatent malaria infections may pose a threat to countries like Namibia that are pursuing malaria elimination. Therefore, assessments of prevalence should not be limited to standard detection methods, such as microscopy and RDT. This study presents the results of the first large-scale survey in Namibia to using molecular methods to measure the prevalence of malaria infections. According to the survey LAMP results, prevalence of infection in the Zambezi region of northeastern Namibia was low at 2.2%, and almost half of prevalent infections were subclinical and almost none were detectable by the standard point-of-care diagnostic RDT. Among the demographic and epidemiologic risk factors assessed, agricultural and cattle herding occupations were significantly associated with LAMP positivity.
The low diagnostic accuracy of RDTs in this setting is consistent with other studies that have found limited sensitivity of RDTs to detect low density infections with less than 100 to 200 parasites/μL [25]. In a meta-analysis comparing diagnostics for the detection of asymptomatic P. falciparum infection in over 30,000 individuals, mainly from low transmission settings, the prevalence of infection by RDT was 41% of the prevalence detected by molecular testing [3]. Similarly, in this study, the 0.8% prevalence of infection by RDT represented 36.4% of the 2.2% prevalence by LAMP, and after excluding LAMP negatives (including 15 of the 16 RDT positives), sensitivity of RDT using LAMP as gold standard was 2.4% (1 of 43 LAMP positives). Apart from the limited sensitivity of RDT to low density infections, other potential explanations for the false negative RDT results were considered, such as limited sensitivity of the PAN/Pf RDT to detect non-falciparum infection [26]. However, all samples positive by genus-specific LAMP testing were positive by P. falciparum specific LAMP testing, and no non-falciparum infections were identified by PCR. Absence of HRP-2 antigen, the target for P. falciparum RDTs, has been reported in Africa and may be another contributing factor for false negative RDT results [27, 28]. Furthermore, 14 of the 16 RDT positives were LAMP or nPCR negative, potentially due to persistence of HRP-2 antigen which has been reported to remain in the bloodstream several weeks after successful treatment [29].
A key finding from this study was a higher risk of infection in individuals engaged in agricultural occupations and cattle herding. As it has been reported in other low transmission settings, outdoor occupations may increase exposure to mosquito bites [7, 30]. Furthermore, ITNs and IRS only provide protection from indoor biting. In low transmission settings, adult age has been frequently found to be associated with infection, presumably due to occupation and behavioural factors [7]. Results identified a trend of infection association with adult age, though the relationship was not statistically significant (Table 3). Male gender, bed net use, IRS coverage, lower socioeconomic status, and international travel, were not associated with infection, in contrast to results from a recent case–control study from Engela, in northern Namibia [31]. Travel may not appear to be associated with infection in the current survey because such a small proportion of the sample reported international travel (0.9% in Zambezi versus 5% in Engela). Also, because the survey was conducted in April and only assessed travel in the prior 8 weeks, it did not capture travel details from the holiday season when travel peaks. Future work to better understand imported malaria should obtain more detailed travel history [32]. Finally, as geographical clustering of infections was not observed, there was no clear spatial risk associated with malaria infection. This could be due to the small number of cases observed. Also, the study was not powered or designed to examine spatial clustering.
To examine coverage or availability of health care services, health-seeking behaviour was assessed among subjects who reported fever in the prior 2 weeks. There were no differences between LAMP positive and negative subjects in terms of care-seeking at a private versus public facility, time between onset of symptoms and care-seeking, or reasons for seeking or not seeking care. However, there was a trend in the association between LAMP positivity and not seeking care. Improved healthcare access could decrease the number of people in communities with malaria symptoms who do not seek care and consequently increase the likelihood of transmitting infections to mosquitos. However, if these infections were subpatent at time of presentation, there may be indication for more sensitive diagnostics in the clinical setting. Even with improved malaria care-seeking and improved point-of-care diagnostics in the clinical setting, there remains the challenge of subclinical infections, which may require a community-based screening and treatment approach using more sensitive diagnostics, or presumptive treatment [33].
There were some limitations to this study. First, cross-sectional designs are suboptimal for identification of risk factors in low transmission settings due to the low number of cases and challenges in determining causality in the relationships between risk factors and prevalent infections. Indeed, the malaria incidence in 2015 was historically low, largely due to a drought in southern Africa. Another drawback was that the classification of subclinical infection was based on self-reported history of fever in the prior 2 weeks, a subjective assessment which may not accurately reflect symptomatology. Further, chronic subpatent infection can persist for months and the fever assessment of just 2 weeks was limited [34]. Cohort studies with regular measurement of temperature and more detailed assessment of symptoms would be a stronger study design, but impractical in this low transmission setting due to the low prevalence of infection. Finally, very low-density infections may have been missed because high blood volumes were not collected and an ultrasensitive molecular detection method was not used [35]. There is a growing body of evidence suggesting near equivalence of LAMP to nPCR [20, 3638] and the use of a higher volume of template DNA for LAMP compared to nPCR likely helped to improve the sensitivity of LAMP. However, to better elucidate the extent of low-density infection and the numerical distribution of parasite density, future studies could utilize more sensitive detection methods.
This study is the first large-scale malaria cross-sectional survey in Namibia using molecular testing and highlighted the importance of subpatent infections in this low transmission setting [11]. Fever history and standard RDTs do not appear useful to address this burden. Achievement of malaria elimination may require active case detection using more sensitive point-of-care diagnostics or presumptive treatment (e.g. mass drug administration). Agricultural occupations and cattle herding were associated with a higher risk of infection and achievement of malaria elimination will likely require intervention strategies that target this high-risk population.

Authors’ contributions

MSH, AB, DM, and RG led the conception and study design. JS, IK, HS, and PU contributed to the study design. PM, KR, MT, JS, GK, CM, MM, MC, and BG supported study implementation, data collection, and laboratory testing. PM MSH and BW performed data cleaning and data analyses. PM MSH and BW wrote the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We are grateful to all residents of Zambezi region for their help and cooperation with the study, the national and regional Ministry of Health and Social Services, and the local traditional leadership for their support. The authors would also like to acknowledge Ricky Simwanza, Simataa Nyathi, Flavian Libita, Carmen Cueto, and Erastus Unity Haindongo for their support of field and laboratory work.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The dataset supporting the conclusions of this article can be requested from the Namibia Ministry of Health and Social Services.
Not applicable.
Institutional Review Board approval for this study was obtained from the University of California San Francisco, the University of Namibia, the Ministry of Health and Social Services of Namibia, and the University of Texas Southwestern. Written consent by signature or finger print was provided from all consenting participants. Consent of a parent or guardian was obtained for those younger than age 18 years. Assent was collected for all children over 12 years old.

Funding

This work was supported by Grants from the Novartis Foundation (A122666), Horchow Family Fund (Grant 5300375400 to MSH), and the Hellen Diller Foundation (Grant to PM).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Tadesse FG, Pett H, Baidjoe A, Lanke K, Grignard L, Sutherland C, et al. Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test. Malar J. 2015;14:303.CrossRef Tadesse FG, Pett H, Baidjoe A, Lanke K, Grignard L, Sutherland C, et al. Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test. Malar J. 2015;14:303.CrossRef
2.
Zurück zum Zitat Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.CrossRef Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.CrossRef
3.
Zurück zum Zitat Wu L, van den Hoogen LL, Slater H, Walker PG, Ghani AC, Drakeley CJ, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528:S86–93.CrossRef Wu L, van den Hoogen LL, Slater H, Walker PG, Ghani AC, Drakeley CJ, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528:S86–93.CrossRef
4.
Zurück zum Zitat Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013;208:2017–24.CrossRef Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013;208:2017–24.CrossRef
5.
Zurück zum Zitat Tietje K, Hawkins K, Clerk C, Ebels K, McGray S, Crudder C, Okell L, et al. The essential role of infection-detection technologies for malaria elimination and eradication. Trends Parasitol. 2014;30:259–66.CrossRef Tietje K, Hawkins K, Clerk C, Ebels K, McGray S, Crudder C, Okell L, et al. The essential role of infection-detection technologies for malaria elimination and eradication. Trends Parasitol. 2014;30:259–66.CrossRef
6.
Zurück zum Zitat Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, et al. ‘Asymptomatic’ malaria: a chronic and debilitating infection that should be treated. PLoS Med. 2016;13:e1001942.CrossRef Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, et al. ‘Asymptomatic’ malaria: a chronic and debilitating infection that should be treated. PLoS Med. 2016;13:e1001942.CrossRef
7.
Zurück zum Zitat Cotter C, Sturrock HJW, Hsiang MS, Liu J, Phillips AA, Hwang J, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013;382:900–11.CrossRef Cotter C, Sturrock HJW, Hsiang MS, Liu J, Phillips AA, Hwang J, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013;382:900–11.CrossRef
8.
Zurück zum Zitat Sturrock HJ, Novotny JM, Kunene S, Dlamini S, Zulu Z, Cohen JM, et al. Reactive case detection for malaria elimination: real-life experience from an ongoing program in Swaziland. PLoS One. 2013;8:e63830.CrossRef Sturrock HJ, Novotny JM, Kunene S, Dlamini S, Zulu Z, Cohen JM, et al. Reactive case detection for malaria elimination: real-life experience from an ongoing program in Swaziland. PLoS One. 2013;8:e63830.CrossRef
9.
Zurück zum Zitat Wen S, Harvard KE, Gueye CS, Canavati SE, Chancellor A, Ahmed BN, et al. Targeting populations at higher risk for malaria: a survey of national malaria elimination programmes in the Asia Pacific. Malar J. 2016;15:271.CrossRef Wen S, Harvard KE, Gueye CS, Canavati SE, Chancellor A, Ahmed BN, et al. Targeting populations at higher risk for malaria: a survey of national malaria elimination programmes in the Asia Pacific. Malar J. 2016;15:271.CrossRef
10.
Zurück zum Zitat Ministry of Health and Social Services. Malaria strategic plan (2010–2017). Windhoek: MOHSS; 2010. Ministry of Health and Social Services. Malaria strategic plan (2010–2017). Windhoek: MOHSS; 2010.
11.
Zurück zum Zitat Government of the Republic of Namibia Ministry of Health and Social Services. Malaria indicator survey in Namibia Windhoek, Namibia; 2014. Government of the Republic of Namibia Ministry of Health and Social Services. Malaria indicator survey in Namibia Windhoek, Namibia; 2014.
12.
Zurück zum Zitat Smith Gueye C, Gerigk M, Newby G, Lourenco C, Uusiku P, Liu J. Namibia’s path toward malaria elimination: a case study of malaria strategies and costs along the northern border. BMC Public Health. 2014;14:1190.CrossRef Smith Gueye C, Gerigk M, Newby G, Lourenco C, Uusiku P, Liu J. Namibia’s path toward malaria elimination: a case study of malaria strategies and costs along the northern border. BMC Public Health. 2014;14:1190.CrossRef
13.
Zurück zum Zitat Government of the Republic of Namibia National Vector-borne Diseases Control Programme. Malaria annual report 2014/2015. Ministry of Health and Social Services, Republic of Namibia, Windhoek; 2015. Government of the Republic of Namibia National Vector-borne Diseases Control Programme. Malaria annual report 2014/2015. Ministry of Health and Social Services, Republic of Namibia, Windhoek; 2015.
14.
Zurück zum Zitat Coetzee M, Craig M, le Sueur D. Distribution of African malaria mosquitoes belonging to the Anopheles gambiae complex. Parasitol Today. 2000;16:74–7.CrossRef Coetzee M, Craig M, le Sueur D. Distribution of African malaria mosquitoes belonging to the Anopheles gambiae complex. Parasitol Today. 2000;16:74–7.CrossRef
15.
Zurück zum Zitat Government of the Republic of Namibia Statistics Agency: Zambezi 2011 Census Regional Profile Windhoek, Namibia; 2014. Government of the Republic of Namibia Statistics Agency: Zambezi 2011 Census Regional Profile Windhoek, Namibia; 2014.
16.
Zurück zum Zitat Namibia Ministry of Health and Social Services: Namibia Demographic and Health Survey Windhoek, Namibia; 2013. Namibia Ministry of Health and Social Services: Namibia Demographic and Health Survey Windhoek, Namibia; 2013.
17.
Zurück zum Zitat Gorstein J, Sullivan K, Parvanta I, Begin F. Indicators and methods for cross-sectional surveys of vitamin and mineral status of populations. CDC: Micronutrient Initiave; 2007. Gorstein J, Sullivan K, Parvanta I, Begin F. Indicators and methods for cross-sectional surveys of vitamin and mineral status of populations. CDC: Micronutrient Initiave; 2007.
18.
Zurück zum Zitat Namibia Ministry of Health and Social Services. National policy on malaria. Windhoek; 2014. Namibia Ministry of Health and Social Services. National policy on malaria. Windhoek; 2014.
19.
Zurück zum Zitat Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565–8.CrossRef Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565–8.CrossRef
20.
Zurück zum Zitat Hopkins H, Gonzalez IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, et al. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis. 2013;208:645–52.CrossRef Hopkins H, Gonzalez IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, et al. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis. 2013;208:645–52.CrossRef
21.
Zurück zum Zitat Steenkeste N, Incardona S, Chy S, Duval L, Ekala MT, Lim P, et al. Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J. 2009;8:86.CrossRef Steenkeste N, Incardona S, Chy S, Duval L, Ekala MT, Lim P, et al. Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J. 2009;8:86.CrossRef
22.
Zurück zum Zitat West BT. Accounting for multi-stage sample designs in complex sample variance estimation Michigan program in survey methodology. Michigan: University of Michigan; 2014. West BT. Accounting for multi-stage sample designs in complex sample variance estimation Michigan program in survey methodology. Michigan: University of Michigan; 2014.
23.
Zurück zum Zitat Kish L. Sampling organizations and groups of unequal sizes. Am Sociol Rev. 1965;30:564–72.CrossRef Kish L. Sampling organizations and groups of unequal sizes. Am Sociol Rev. 1965;30:564–72.CrossRef
24.
Zurück zum Zitat Kulldorff M. A spatial scan statistic. Commun Statist Theory Methods. 1997;26:1481–96.CrossRef Kulldorff M. A spatial scan statistic. Commun Statist Theory Methods. 1997;26:1481–96.CrossRef
25.
Zurück zum Zitat Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol. 2006;4:S7–20.CrossRef Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol. 2006;4:S7–20.CrossRef
26.
Zurück zum Zitat WHO. Malaria rapid diagnostic test performance: summary results of WHO product testing of malaria RDTs: rounds 1–6 (2008–2015). Geneva: World Health Organization; 2008. WHO. Malaria rapid diagnostic test performance: summary results of WHO product testing of malaria RDTs: rounds 1–6 (2008–2015). Geneva: World Health Organization; 2008.
27.
Zurück zum Zitat Parr JB, Verity R, Doctor SM, Janko M, Carey-Ewend K, Turman BJ, et al. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey. J Infect Dis. 2017;216:36–44.CrossRef Parr JB, Verity R, Doctor SM, Janko M, Carey-Ewend K, Turman BJ, et al. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey. J Infect Dis. 2017;216:36–44.CrossRef
28.
Zurück zum Zitat Kozycki CT, Umulisa N, Rulisa S, Mwikarago EI, Musabyimana JP, Habimana JP, et al. False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission. Malar J. 2017;16:123.CrossRef Kozycki CT, Umulisa N, Rulisa S, Mwikarago EI, Musabyimana JP, Habimana JP, et al. False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission. Malar J. 2017;16:123.CrossRef
29.
Zurück zum Zitat Dalrymple U, Arambepola R, Gething PW, Cameron E. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar J. 2018;17:228.CrossRef Dalrymple U, Arambepola R, Gething PW, Cameron E. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar J. 2018;17:228.CrossRef
30.
Zurück zum Zitat Zaw MT, Thant M, Hlaing TM, Aung NZ, Thu M, Phumchuea K, et al. Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar. Malar J. 2017;16:138.CrossRef Zaw MT, Thant M, Hlaing TM, Aung NZ, Thu M, Phumchuea K, et al. Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar. Malar J. 2017;16:138.CrossRef
31.
Zurück zum Zitat Smith JL, Auala J, Haindongo E, Uusiku P, Gosling R, Kleinschmidt I, et al. Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malar J. 2017;16:70.CrossRef Smith JL, Auala J, Haindongo E, Uusiku P, Gosling R, Kleinschmidt I, et al. Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malar J. 2017;16:70.CrossRef
32.
Zurück zum Zitat Ruktanonchai NW, DeLeenheer P, Tatem AJ, Alegana VA, Caughlin TT, Zu Erbach-Schoenberg E, et al. Identifying malaria transmission foci for elimination using human mobility data. PLoS Comput Biol. 2016;12:e1004846.CrossRef Ruktanonchai NW, DeLeenheer P, Tatem AJ, Alegana VA, Caughlin TT, Zu Erbach-Schoenberg E, et al. Identifying malaria transmission foci for elimination using human mobility data. PLoS Comput Biol. 2016;12:e1004846.CrossRef
33.
Zurück zum Zitat Medzihradsky OF, Kleinschmidt I, Mumbengegwi D, Roberts KW, McCreesh P, Dufour MK, et al. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia. BMJ Open. 2018;8:e019294.CrossRef Medzihradsky OF, Kleinschmidt I, Mumbengegwi D, Roberts KW, McCreesh P, Dufour MK, et al. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia. BMJ Open. 2018;8:e019294.CrossRef
34.
Zurück zum Zitat Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11:623–39.CrossRef Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11:623–39.CrossRef
35.
Zurück zum Zitat Imwong M, Stepniewska K, Tripura R, Peto TJ, Lwin KM, Vihokhern B, et al. Numerical distributions of parasite densities during asymptomatic malaria. J Infect Dis. 2016;213:1322–9.CrossRef Imwong M, Stepniewska K, Tripura R, Peto TJ, Lwin KM, Vihokhern B, et al. Numerical distributions of parasite densities during asymptomatic malaria. J Infect Dis. 2016;213:1322–9.CrossRef
36.
Zurück zum Zitat Polley SD, Gonzalez IJ, Mohamed D, Daly R, Bowers K, Watson J, et al. Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis. 2013;208:637–44.CrossRef Polley SD, Gonzalez IJ, Mohamed D, Daly R, Bowers K, Watson J, et al. Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis. 2013;208:637–44.CrossRef
37.
Zurück zum Zitat Herdiana H, Cotter C, Coutrier FN, Zarlinda I, Zelman BW, Tirta YK, et al. Malaria risk factor assessment using active and passive surveillance data from Aceh Besar, Indonesia, a low endemic, malaria elimination setting with Plasmodium knowlesi, Plasmodium vivax, and Plasmodium falciparum. Malar J. 2016;15:468.CrossRef Herdiana H, Cotter C, Coutrier FN, Zarlinda I, Zelman BW, Tirta YK, et al. Malaria risk factor assessment using active and passive surveillance data from Aceh Besar, Indonesia, a low endemic, malaria elimination setting with Plasmodium knowlesi, Plasmodium vivax, and Plasmodium falciparum. Malar J. 2016;15:468.CrossRef
38.
Zurück zum Zitat Tegegne B, Getie S, Lemma W, Mohon AN, Pillai DR. Performance of loop-mediated isothermal amplification (LAMP) for the diagnosis of malaria among malaria suspected pregnant women in Northwest Ethiopia. Malar J. 2017;16:34.CrossRef Tegegne B, Getie S, Lemma W, Mohon AN, Pillai DR. Performance of loop-mediated isothermal amplification (LAMP) for the diagnosis of malaria among malaria suspected pregnant women in Northwest Ethiopia. Malar J. 2017;16:34.CrossRef
Metadaten
Titel
Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia
verfasst von
Patrick McCreesh
Davis Mumbengegwi
Kathryn Roberts
Munyaradzi Tambo
Jennifer Smith
Brooke Whittemore
Gerard Kelly
Caitlin Moe
Max Murphy
Mukosha Chisenga
Bryan Greenhouse
Henry Ntuku
Immo Kleinschmidt
Hugh Sturrock
Petrina Uusiku
Roland Gosling
Adam Bennett
Michelle S. Hsiang
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Malaria Journal / Ausgabe 1/2018
Elektronische ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-018-2626-5

Weitere Artikel der Ausgabe 1/2018

Malaria Journal 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.